Michael joined Sofinnova as Senior Associate in 2013 and has been involved ever since in the investment activity of Sofinnova in industrial biotech. He focuses on early stage deals in Europe and North America with applications in chemicals, materials, agriculture, food, feed and synthetic biology. He sits as an observer on Comet Bio board and sits on the boards of EnobraQ and Afyren. He has been the CEO of EnobraQ (a Sofinnova green Seed Fund portfolio company) for 2 years, and has transitioned out of the company to focus on investments. Prior to Sofinnova, Michael spent six years in Industrial biotech start-ups, holding business development positions. After completing his PhD studies, Michael was a consultant focused on R&D’s strategic and organizational issues. Michael is a graduate engineer from Ecole Polytechnique and holds a PhD in organic chemistry from Paris X Orsay University.